The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Etoricoxib is a selective COX-2 inhibitor used to relieve dental pain after moderate surgery as a short-term treatment and inflammation and pain symptoms of various forms of arthritis.
The global Etoricoxib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Etoricoxib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Etoricoxib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Etoricoxib include Morepen Laboratories, Merck & Co, Frosst Iberica SA, Metrochem API, Atom Pharma, Hema Pharmaceuticals, Beijing Tide Pharmaceutical, Qilu Pharmaceutical and Shanghai Shyndec Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Etoricoxib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Etoricoxib.
Report Scope
The Etoricoxib market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Etoricoxib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Etoricoxib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Morepen Laboratories
Merck & Co
Frosst Iberica SA
Metrochem API
Atom Pharma
Hema Pharmaceuticals
Beijing Tide Pharmaceutical
Qilu Pharmaceutical
Shanghai Shyndec Pharmaceutical
Easton Biopharmaceuticals
Segment by Type
30 mg
60 mg
90 mg
120 mg
Segment by Application
Hospital
Pharmacy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Etoricoxib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Etoricoxib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Etoricoxib is a selective COX-2 inhibitor used to relieve dental pain after moderate surgery as a short-term treatment and inflammation and pain symptoms of various forms of arthritis.
The global Etoricoxib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Etoricoxib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Etoricoxib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Etoricoxib include Morepen Laboratories, Merck & Co, Frosst Iberica SA, Metrochem API, Atom Pharma, Hema Pharmaceuticals, Beijing Tide Pharmaceutical, Qilu Pharmaceutical and Shanghai Shyndec Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Etoricoxib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Etoricoxib.
Report Scope
The Etoricoxib market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Etoricoxib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Etoricoxib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Morepen Laboratories
Merck & Co
Frosst Iberica SA
Metrochem API
Atom Pharma
Hema Pharmaceuticals
Beijing Tide Pharmaceutical
Qilu Pharmaceutical
Shanghai Shyndec Pharmaceutical
Easton Biopharmaceuticals
Segment by Type
30 mg
60 mg
90 mg
120 mg
Segment by Application
Hospital
Pharmacy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Etoricoxib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Etoricoxib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Etoricoxib Market Overview
1.1 Product Overview and Scope of Etoricoxib
1.2 Etoricoxib Segment by Type
1.2.1 Global Etoricoxib Market Value Comparison by Type (2024-2030)
1.2.2 30 mg
1.2.3 60 mg
1.2.4 90 mg
1.2.5 120 mg
1.3 Etoricoxib Segment by Application
1.3.1 Global Etoricoxib Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Etoricoxib Market Size Estimates and Forecasts
1.4.1 Global Etoricoxib Revenue 2019-2030
1.4.2 Global Etoricoxib Sales 2019-2030
1.4.3 Global Etoricoxib Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Etoricoxib Market Competition by Manufacturers
2.1 Global Etoricoxib Sales Market Share by Manufacturers (2019-2024)
2.2 Global Etoricoxib Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Etoricoxib Average Price by Manufacturers (2019-2024)
2.4 Global Etoricoxib Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Etoricoxib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Etoricoxib, Product Type & Application
2.7 Etoricoxib Market Competitive Situation and Trends
2.7.1 Etoricoxib Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Etoricoxib Players Market Share by Revenue
2.7.3 Global Etoricoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Etoricoxib Retrospective Market Scenario by Region
3.1 Global Etoricoxib Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Etoricoxib Global Etoricoxib Sales by Region: 2019-2030
3.2.1 Global Etoricoxib Sales by Region: 2019-2024
3.2.2 Global Etoricoxib Sales by Region: 2025-2030
3.3 Global Etoricoxib Global Etoricoxib Revenue by Region: 2019-2030
3.3.1 Global Etoricoxib Revenue by Region: 2019-2024
3.3.2 Global Etoricoxib Revenue by Region: 2025-2030
3.4 North America Etoricoxib Market Facts & Figures by Country
3.4.1 North America Etoricoxib Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Etoricoxib Sales by Country (2019-2030)
3.4.3 North America Etoricoxib Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Etoricoxib Market Facts & Figures by Country
3.5.1 Europe Etoricoxib Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Etoricoxib Sales by Country (2019-2030)
3.5.3 Europe Etoricoxib Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Etoricoxib Market Facts & Figures by Country
3.6.1 Asia Pacific Etoricoxib Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Etoricoxib Sales by Country (2019-2030)
3.6.3 Asia Pacific Etoricoxib Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Etoricoxib Market Facts & Figures by Country
3.7.1 Latin America Etoricoxib Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Etoricoxib Sales by Country (2019-2030)
3.7.3 Latin America Etoricoxib Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Etoricoxib Market Facts & Figures by Country
3.8.1 Middle East and Africa Etoricoxib Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Etoricoxib Sales by Country (2019-2030)
3.8.3 Middle East and Africa Etoricoxib Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Etoricoxib Sales by Type (2019-2030)
4.1.1 Global Etoricoxib Sales by Type (2019-2024)
4.1.2 Global Etoricoxib Sales by Type (2025-2030)
4.1.3 Global Etoricoxib Sales Market Share by Type (2019-2030)
4.2 Global Etoricoxib Revenue by Type (2019-2030)
4.2.1 Global Etoricoxib Revenue by Type (2019-2024)
4.2.2 Global Etoricoxib Revenue by Type (2025-2030)
4.2.3 Global Etoricoxib Revenue Market Share by Type (2019-2030)
4.3 Global Etoricoxib Price by Type (2019-2030)
5 Segment by Application
5.1 Global Etoricoxib Sales by Application (2019-2030)
5.1.1 Global Etoricoxib Sales by Application (2019-2024)
5.1.2 Global Etoricoxib Sales by Application (2025-2030)
5.1.3 Global Etoricoxib Sales Market Share by Application (2019-2030)
5.2 Global Etoricoxib Revenue by Application (2019-2030)
5.2.1 Global Etoricoxib Revenue by Application (2019-2024)
5.2.2 Global Etoricoxib Revenue by Application (2025-2030)
5.2.3 Global Etoricoxib Revenue Market Share by Application (2019-2030)
5.3 Global Etoricoxib Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Morepen Laboratories
6.1.1 Morepen Laboratories Corporation Information
6.1.2 Morepen Laboratories Description and Business Overview
6.1.3 Morepen Laboratories Etoricoxib Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Morepen Laboratories Etoricoxib Product Portfolio
6.1.5 Morepen Laboratories Recent Developments/Updates
6.2 Merck & Co
6.2.1 Merck & Co Corporation Information
6.2.2 Merck & Co Description and Business Overview
6.2.3 Merck & Co Etoricoxib Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck & Co Etoricoxib Product Portfolio
6.2.5 Merck & Co Recent Developments/Updates
6.3 Frosst Iberica SA
6.3.1 Frosst Iberica SA Corporation Information
6.3.2 Frosst Iberica SA Description and Business Overview
6.3.3 Frosst Iberica SA Etoricoxib Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Frosst Iberica SA Etoricoxib Product Portfolio
6.3.5 Frosst Iberica SA Recent Developments/Updates
6.4 Metrochem API
6.4.1 Metrochem API Corporation Information
6.4.2 Metrochem API Description and Business Overview
6.4.3 Metrochem API Etoricoxib Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Metrochem API Etoricoxib Product Portfolio
6.4.5 Metrochem API Recent Developments/Updates
6.5 Atom Pharma
6.5.1 Atom Pharma Corporation Information
6.5.2 Atom Pharma Description and Business Overview
6.5.3 Atom Pharma Etoricoxib Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Atom Pharma Etoricoxib Product Portfolio
6.5.5 Atom Pharma Recent Developments/Updates
6.6 Hema Pharmaceuticals
6.6.1 Hema Pharmaceuticals Corporation Information
6.6.2 Hema Pharmaceuticals Description and Business Overview
6.6.3 Hema Pharmaceuticals Etoricoxib Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hema Pharmaceuticals Etoricoxib Product Portfolio
6.6.5 Hema Pharmaceuticals Recent Developments/Updates
6.7 Beijing Tide Pharmaceutical
6.6.1 Beijing Tide Pharmaceutical Corporation Information
6.6.2 Beijing Tide Pharmaceutical Description and Business Overview
6.6.3 Beijing Tide Pharmaceutical Etoricoxib Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beijing Tide Pharmaceutical Etoricoxib Product Portfolio
6.7.5 Beijing Tide Pharmaceutical Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Corporation Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Etoricoxib Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Qilu Pharmaceutical Etoricoxib Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
6.9 Shanghai Shyndec Pharmaceutical
6.9.1 Shanghai Shyndec Pharmaceutical Corporation Information
6.9.2 Shanghai Shyndec Pharmaceutical Description and Business Overview
6.9.3 Shanghai Shyndec Pharmaceutical Etoricoxib Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai Shyndec Pharmaceutical Etoricoxib Product Portfolio
6.9.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
6.10 Easton Biopharmaceuticals
6.10.1 Easton Biopharmaceuticals Corporation Information
6.10.2 Easton Biopharmaceuticals Description and Business Overview
6.10.3 Easton Biopharmaceuticals Etoricoxib Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Easton Biopharmaceuticals Etoricoxib Product Portfolio
6.10.5 Easton Biopharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Etoricoxib Industry Chain Analysis
7.2 Etoricoxib Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Etoricoxib Production Mode & Process
7.4 Etoricoxib Sales and Marketing
7.4.1 Etoricoxib Sales Channels
7.4.2 Etoricoxib Distributors
7.5 Etoricoxib Customers
8 Etoricoxib Market Dynamics
8.1 Etoricoxib Industry Trends
8.2 Etoricoxib Market Drivers
8.3 Etoricoxib Market Challenges
8.4 Etoricoxib Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Etoricoxib Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Etoricoxib Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Etoricoxib Market Competitive Situation by Manufacturers in 2023
Table 4. Global Etoricoxib Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Etoricoxib Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Etoricoxib Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Etoricoxib Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Etoricoxib Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Etoricoxib, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Etoricoxib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Etoricoxib, Product Type & Application
Table 12. Global Key Manufacturers of Etoricoxib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Etoricoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Etoricoxib as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Etoricoxib Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Etoricoxib Sales by Region (2019-2024) & (K Units)
Table 18. Global Etoricoxib Sales Market Share by Region (2019-2024)
Table 19. Global Etoricoxib Sales by Region (2025-2030) & (K Units)
Table 20. Global Etoricoxib Sales Market Share by Region (2025-2030)
Table 21. Global Etoricoxib Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Etoricoxib Revenue Market Share by Region (2019-2024)
Table 23. Global Etoricoxib Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Etoricoxib Revenue Market Share by Region (2025-2030)
Table 25. North America Etoricoxib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Etoricoxib Sales by Country (2019-2024) & (K Units)
Table 27. North America Etoricoxib Sales by Country (2025-2030) & (K Units)
Table 28. North America Etoricoxib Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Etoricoxib Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Etoricoxib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Etoricoxib Sales by Country (2019-2024) & (K Units)
Table 32. Europe Etoricoxib Sales by Country (2025-2030) & (K Units)
Table 33. Europe Etoricoxib Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Etoricoxib Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Etoricoxib Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Etoricoxib Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Etoricoxib Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Etoricoxib Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Etoricoxib Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Etoricoxib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Etoricoxib Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Etoricoxib Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Etoricoxib Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Etoricoxib Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Etoricoxib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Etoricoxib Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Etoricoxib Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Etoricoxib Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Etoricoxib Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Etoricoxib Sales (K Units) by Type (2019-2024)
Table 51. Global Etoricoxib Sales (K Units) by Type (2025-2030)
Table 52. Global Etoricoxib Sales Market Share by Type (2019-2024)
Table 53. Global Etoricoxib Sales Market Share by Type (2025-2030)
Table 54. Global Etoricoxib Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Etoricoxib Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Etoricoxib Revenue Market Share by Type (2019-2024)
Table 57. Global Etoricoxib Revenue Market Share by Type (2025-2030)
Table 58. Global Etoricoxib Price (US$/Unit) by Type (2019-2024)
Table 59. Global Etoricoxib Price (US$/Unit) by Type (2025-2030)
Table 60. Global Etoricoxib Sales (K Units) by Application (2019-2024)
Table 61. Global Etoricoxib Sales (K Units) by Application (2025-2030)
Table 62. Global Etoricoxib Sales Market Share by Application (2019-2024)
Table 63. Global Etoricoxib Sales Market Share by Application (2025-2030)
Table 64. Global Etoricoxib Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Etoricoxib Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Etoricoxib Revenue Market Share by Application (2019-2024)
Table 67. Global Etoricoxib Revenue Market Share by Application (2025-2030)
Table 68. Global Etoricoxib Price (US$/Unit) by Application (2019-2024)
Table 69. Global Etoricoxib Price (US$/Unit) by Application (2025-2030)
Table 70. Morepen Laboratories Corporation Information
Table 71. Morepen Laboratories Description and Business Overview
Table 72. Morepen Laboratories Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Morepen Laboratories Etoricoxib Product
Table 74. Morepen Laboratories Recent Developments/Updates
Table 75. Merck & Co Corporation Information
Table 76. Merck & Co Description and Business Overview
Table 77. Merck & Co Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Merck & Co Etoricoxib Product
Table 79. Merck & Co Recent Developments/Updates
Table 80. Frosst Iberica SA Corporation Information
Table 81. Frosst Iberica SA Description and Business Overview
Table 82. Frosst Iberica SA Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Frosst Iberica SA Etoricoxib Product
Table 84. Frosst Iberica SA Recent Developments/Updates
Table 85. Metrochem API Corporation Information
Table 86. Metrochem API Description and Business Overview
Table 87. Metrochem API Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Metrochem API Etoricoxib Product
Table 89. Metrochem API Recent Developments/Updates
Table 90. Atom Pharma Corporation Information
Table 91. Atom Pharma Description and Business Overview
Table 92. Atom Pharma Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Atom Pharma Etoricoxib Product
Table 94. Atom Pharma Recent Developments/Updates
Table 95. Hema Pharmaceuticals Corporation Information
Table 96. Hema Pharmaceuticals Description and Business Overview
Table 97. Hema Pharmaceuticals Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Hema Pharmaceuticals Etoricoxib Product
Table 99. Hema Pharmaceuticals Recent Developments/Updates
Table 100. Beijing Tide Pharmaceutical Corporation Information
Table 101. Beijing Tide Pharmaceutical Description and Business Overview
Table 102. Beijing Tide Pharmaceutical Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Beijing Tide Pharmaceutical Etoricoxib Product
Table 104. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 105. Qilu Pharmaceutical Corporation Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Qilu Pharmaceutical Etoricoxib Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. Shanghai Shyndec Pharmaceutical Corporation Information
Table 111. Shanghai Shyndec Pharmaceutical Description and Business Overview
Table 112. Shanghai Shyndec Pharmaceutical Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Shanghai Shyndec Pharmaceutical Etoricoxib Product
Table 114. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
Table 115. Easton Biopharmaceuticals Corporation Information
Table 116. Easton Biopharmaceuticals Description and Business Overview
Table 117. Easton Biopharmaceuticals Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Easton Biopharmaceuticals Etoricoxib Product
Table 119. Easton Biopharmaceuticals Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Etoricoxib Distributors List
Table 123. Etoricoxib Customers List
Table 124. Etoricoxib Market Trends
Table 125. Etoricoxib Market Drivers
Table 126. Etoricoxib Market Challenges
Table 127. Etoricoxib Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Etoricoxib
Figure 2. Global Etoricoxib Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Etoricoxib Market Share by Type in 2023 & 2030
Figure 4. 30 mg Product Picture
Figure 5. 60 mg Product Picture
Figure 6. 90 mg Product Picture
Figure 7. 120 mg Product Picture
Figure 8. Global Etoricoxib Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Etoricoxib Market Share by Application in 2023 & 2030
Figure 10. Hospital
Figure 11. Pharmacy
Figure 12. Others
Figure 13. Global Etoricoxib Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Etoricoxib Market Size (2019-2030) & (US$ Million)
Figure 15. Global Etoricoxib Sales (2019-2030) & (K Units)
Figure 16. Global Etoricoxib Average Price (US$/Unit) & (2019-2030)
Figure 17. Etoricoxib Report Years Considered
Figure 18. Etoricoxib Sales Share by Manufacturers in 2023
Figure 19. Global Etoricoxib Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Etoricoxib Players: Market Share by Revenue in 2023
Figure 21. Etoricoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Etoricoxib Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Etoricoxib Sales Market Share by Country (2019-2030)
Figure 24. North America Etoricoxib Revenue Market Share by Country (2019-2030)
Figure 25. United States Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Etoricoxib Sales Market Share by Country (2019-2030)
Figure 28. Europe Etoricoxib Revenue Market Share by Country (2019-2030)
Figure 29. Germany Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Etoricoxib Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Etoricoxib Revenue Market Share by Region (2019-2030)
Figure 36. China Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Etoricoxib Sales Market Share by Country (2019-2030)
Figure 46. Latin America Etoricoxib Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Etoricoxib Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Etoricoxib Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Etoricoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Etoricoxib by Type (2019-2030)
Figure 56. Global Revenue Market Share of Etoricoxib by Type (2019-2030)
Figure 57. Global Etoricoxib Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Etoricoxib by Application (2019-2030)
Figure 59. Global Revenue Market Share of Etoricoxib by Application (2019-2030)
Figure 60. Global Etoricoxib Price (US$/Unit) by Application (2019-2030)
Figure 61. Etoricoxib Value Chain
Figure 62. Etoricoxib Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
